by Brittany B. Martabano, Steven Dow, Lyndah Chow, Margaret M. V. Williams, Maura K. Mack, Rebecca Bellone, Kathryn L. Wotman
Objective
To determine the safety and efficacy of perilesional human recombinant interferon alpha-2b (IFNα2b) for treatment of periocular squamous cell carcinoma (PSCC) in horses.
Animals studied
Eleven horses (12 eyes) with PSCC were enrolled in this prospective clinical study with owner consent.
Procedures
Systemically healthy horses were included in the study following confirmation of PSCC via biopsy. Every two weeks for a maximum of six treatments, horses were sedated and perilesional injection of IFNα2b (10 million IU) was performed. Tumors were measured prior to each injection and at one, three, and 12 months after treatment completion. A greater than 50% reduction in tumor size was considered positive response to treatment (i.e., partial or complete response). Development of anti-IFNα2b antibodies was assessed using serum samples obtained after treatment initiation and compared with treatment responses. Antibody concentrations were analyzed using a mixed model. Statistical significance was considered p < 0.05.
Results
Each horse received four to six perilesional injections of IFNα2b. Five of 12 eyes (4/11 horses) responded to treatment. Two of five eyes showed complete resolution of gross PSCC. No systemic adverse effects were seen. Local swelling occurred during treatment protocol in 6/11 horses but resolved without intervention. All horses developed serum anti-IFNα2b antibodies. There was no evidence of statistical difference in antibody concentration between responders and non-responders.
Conclusions
Perilesional administration of IFNα2b was found to be well-tolerated in horses with PSCC, and induced tumor regression in 42% of treated eyes. Treatment failure appears unrelated to the development of IFNα2b antibodies.
The Big Catch: Tacklebox is the hardest 3D platformer I've ever played, 8+ hours long, and a free to play 'prologue' to a bigger, better game on the way
Epic Boss Tim Sweeney says Unreal Engine 6 will be a 'metaverse' joining Fortnite and other Unreal games, including an upcoming 'persistent universe' in development with Disney
I'm terrified for my free time after a few hours with the Dead Cells developer's new frantic co-op roguelike out this month
Disney Dreamlight Valley's next free update, Jungle Getaway, will introduce two new characters